Publication | Closed Access

Synthesis and Evaluation of Efavirenz (SustivaTM) Analogues as HIV-1 Reverse Transcriptase Inhibitors: Replacement of the Cyclopropylacetylene Side Chain

Medicinal ChemistryMedicineNatural SciencesHuman RetrovirusAntiviral Drug DevelopmentAntiviral TherapyMolecular BiologyCyclopropylacetylene Side ChainHivAntiviral DrugPharmacologyAntiviral CompoundDrug Discovery